Trials / Conditions / Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Human Immunodeficiency Virus Type 1 (HIV-1) Infection
5 registered clinical trials studyying Human Immunodeficiency Virus Type 1 (HIV-1) Infection — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591 NCT07266831 | Merck Sharp & Dohme LLC | Phase 2 / Phase 3 |
| Active Not Recruiting | A Study of Islatravir (ISL) and Ulonivirine (ULO) Once Weekly (QW) in Virologically Suppressed Adults With Hum NCT06891066 | Merck Sharp & Dohme LLC | Phase 2 |
| Terminated | Drug-Drug Interaction Study of Vesatolimod in Adults With HIV-1 Who Have Very Low or Undetectable Virus Levels NCT05458102 | Gilead Sciences | Phase 1 |
| Withdrawn | A Study on the Safety and Effectiveness of Rilpivirine Hydrochloride (Edurant) Among Adult Filipino Patients W NCT01692470 | Janssen Pharmaceutica | — |
| Completed | Immunogenicity, Safety, and Tolerability of MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patien NCT01032408 | Chiltern Pesquisa Clinica Ltda | Phase 3 |